Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 15, 2020 - Issue
Submit an article Journal homepage
128
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Reduced Serum Concentration of CC16 Is Associated with Severity of Chronic Obstructive Pulmonary Disease and Contributes to the Diagnosis and Assessment of the Disease

Biaoxue Rong1 Department of Oncology and Gerontology, First Affiliated Hospital, Xi’an Medical University, Xi’an, People’s Republic of ChinaCorrespondence[email protected]
,
Tian Fu2 Department of Respiratory Medicine, Jining No.1 People’s Hospital, Jining, People’s Republic of China
,
Wenlong Gao3 Institute of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou, People’s Republic of China
,
Min Li4 Nursing Department, Binhe New District Branch, Shenmu Hospital, Yulin City, Shaanxi, People’s Republic of China
,
Congxue Rong5 Comprehensive Medical Department, Zhangye Second People Hospital, Zhangye, People’s Republic of China
,
Wen Liu6 Department of Respiratory Medicine, Minqin County People’s Hospital, Minqin, People’s Republic of China
&
Hua Liu7 Department of Respiratory Medicine, Gansu Provincial Hospital, Lanzhou, People’s Republic of China
 show all
Pages 461-470 | Published online: 02 Mar 2020

References

  • BienerAI, DeckerSL, RohdeF. Prevalence and treatment of chronic obstructive pulmonary disease (COPD) in the United States. JAMA. 2019;322(7):602. doi:10.1001/jama.2019.1024131429884
  • BiaoxueR, LiuY, LiM, FuT, GaoW, LiuH. Correlation of serum levels of HIF-1alpha and IL-19 with the disease progression of COPD: a retrospective study. Int J Chron Obstruct Pulmon Dis. 2018;13:3791–3803. doi:10.2147/COPD.S17703430538441
  • BroeckaertF, ClippeA, KnoopsB, HermansC, BernardA. Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann N Y Acad Sci. 2000;923:68–77. doi:10.1111/j.1749-6632.2000.tb05520.x11193780
  • KropskiJA, FremontRD, CalfeeCS, WareLB. Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury. Chest. 2009;135(6):1440–1447. doi:10.1378/chest.08-246519188556
  • Montes de OcaM, Lopez VarelaMV, Laucho-ContrerasME, et al. Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD). Arch Bronconeumol. 2017;53(3):98–106. doi:10.1016/j.arbres.2016.08.01527956034
  • VestboJ, HurdSS, AgustiAG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP22878278
  • VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Respirology. 2017;22(3):575–601.28150362
  • BellingerCR, PetersSP. Outpatient chronic obstructive pulmonary disease management: going for the GOLD. J Allergy Clin Immunol Pract. 2015;3(4):471–478; quiz 479–480. doi:10.1016/j.jaip.2015.04.010
  • LaunoisC, BarbeC, BertinE, et al. The modified medical research council scale for the assessment of dyspnea in daily living in obesity: a pilot study. BMC Pulm Med. 2012;12:61. doi:10.1186/1471-2466-12-6123025326
  • McAuleyDF, MatthayMA. Clara cell protein CC16. A new lung epithelial biomarker for acute lung injury. Chest. 2009;135(6):1408–1410. doi:10.1378/chest.09-030419497890
  • ManninoDM. Biomarkers for chronic obstructive pulmonary disease diagnosis and progression: insights, disappointments and promise. Curr Opin Pulm Med. 2019;25(2):144–149. doi:10.1097/MCP.000000000000054930520743
  • WutzlerS, LehnertT, LaurerH, et al. Circulating levels of Clara cell protein 16 but not surfactant protein D identify and quantify lung damage in patients with multiple injuries. J Trauma. 2011;71(2):E31–E36.21045740
  • Laucho-ContrerasME, PolverinoF, TesfaigziY, PilonA, CelliBR, OwenCA. Club cell protein 16 (CC16) augmentation: a potential disease-modifying approach for chronic obstructive pulmonary disease (COPD). Expert Opin Ther Targets. 2016;20(7):869–883. doi:10.1517/14728222.2016.113908426781659
  • ZhuL, DiPY, WuR, PinkertonKE, ChenY. Repression of CC16 by cigarette smoke (CS) exposure. PLoS One. 2015;10(1):e0116159. doi:10.1371/journal.pone.011615925635997
  • LomasDA, SilvermanEK, EdwardsLD, MillerBE, CoxsonHO, Tal-SingerR. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax. 2008;63(12):1058–1063. doi:10.1136/thx.2008.10257418757456
  • VestboJ, EdwardsLD, ScanlonPD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365(13):1184–1192. doi:10.1056/NEJMoa110548221991892
  • ParkHY, ChurgA, WrightJL, et al. Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(12):1413–1419. doi:10.1164/rccm.201305-0892OC24245748
  • GuerraS, HalonenM, VasquezMM, et al. Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study. Lancet Respir Med. 2015;3(8):613–620. doi:10.1016/S2213-2600(15)00196-426159408
  • Laucho-ContrerasME, PolverinoF, GuptaK, et al. Protective role for club cell secretory protein-16 (CC16) in the development of COPD. Eur Respir J. 2015;45(6):1544–1556. doi:10.1183/09031936.0013421425700379

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.